دسترسی نامحدود
برای کاربرانی که ثبت نام کرده اند
برای ارتباط با ما می توانید از طریق شماره موبایل زیر از طریق تماس و پیامک با ما در ارتباط باشید
در صورت عدم پاسخ گویی از طریق پیامک با پشتیبان در ارتباط باشید
برای کاربرانی که ثبت نام کرده اند
درصورت عدم همخوانی توضیحات با کتاب
از ساعت 7 صبح تا 10 شب
ویرایش: سری: ISBN (شابک) : 9781119636496 ناشر: Wiley-Blackwell سال نشر: 2024 تعداد صفحات: زبان: English فرمت فایل : PDF (درصورت درخواست کاربر به PDF، EPUB یا AZW3 تبدیل می شود) حجم فایل: 7 Mb
در صورت تبدیل فایل کتاب Queenan's Management of High-Risk Pregnancy-An Evidence-Based Approach, 7e (Mar 4, 2024)_(1119636493)_(Wiley-Blackwell) به فرمت های PDF، EPUB، AZW3، MOBI و یا DJVU می توانید به پشتیبان اطلاع دهید تا فایل مورد نظر را تبدیل نمایند.
توجه داشته باشید کتاب مدیریت بارداری پرخطر کوئینان-رویکرد مبتنی بر شواهد، 7e (4 مارس 2024)_(1119636493)_(Wiley-Blackwell) نسخه زبان اصلی می باشد و کتاب ترجمه شده به فارسی نمی باشد. وبسایت اینترنشنال لایبرری ارائه دهنده کتاب های زبان اصلی می باشد و هیچ گونه کتاب ترجمه شده یا نوشته شده به فارسی را ارائه نمی دهد.
مدیریت بارداری پرخطر کوئینن ویرایش جدید متن کلاسیک قدیمی که تمام زمینه های پزشکی پری ناتال را پوشش می دهد. خطر بارداری اطلاعات کاربردی و مفید بالینی در مورد طیف کامل مراقبت های دوران بارداری ارائه می دهد. این مرجع ارزشمند با تمرکز بر تصمیم گیری بالینی، حاوی اطلاعات معتبر و مبتنی بر شواهد در مورد عوامل حاملگی پرخطر، نظارت بیوشیمیایی و بیوفیزیکی، بیماری مادر، عوارض مامایی، ایمنی بیمار در زایمان و زایمان و غیره است. این متن با بیش از 50 فصل مختصر توسط متخصصان برجسته نوشته شده است و شامل پروتکلهای مبتنی بر شواهد، الگوریتمها، مطالعات موردی، اقدامات بالقوه پیامد، داروها و گزارشهای موردی مصور برای اطمینان از بهترین نتایج ممکن برای بیماران جنینی و مادری است. این متن راهنمایی روشنی در مورد مشکلات رایجی که در مدیریت روزانه حاملگی های پرخطر با آن مواجه می شود، ارائه می دهد. ویرایش هفتم کتاب مدیریت بارداری پرخطر کوئینن شامل فصول جدید و به روز شده با جدیدترین اطلاعات مبتنی بر شواهد و پروتکل های موجود در مورد موضوعاتی مانند بیماری های عفونی در بارداری، بخار کردن، زایمان طبیعی واژینال، خونریزی پس از زایمان، بارداری در زنان دارای معلولیت، کم خونی مادر، مالاریا و عفونت HIV. مدیریت بارداری پرخطر کوئینن: رویکرد مبتنی بر شواهد، ویرایش هفتم، مرجع و راهنمای ضروری برای متخصصین زنان و زایمان، متخصصین زنان، کارآموزان OB/GYN، ماماها، و پزشکان اولیه و عمومی است.
Queenan\'s Management of High-Risk Pregnancy The new edition of the long-standing classic text, covering all areas of perinatal medicine Continuing to set the standard for maternal-fetal practice, the seventh edition of Queenan\'s Management of High-Risk Pregnancy provides practical, clinically useful information on the full spectrum of perinatal care. Focused on clinical decision-making, this invaluable reference contains authoritative, evidence-based information on the factors of high-risk pregnancy, biochemical and biophysical monitoring, maternal disease, obstetric complications, patient safety in labor and delivery, and more. With more than 50 concise chapters, this text has been written by leading experts, and contains evidence-based protocols, algorithms, case studies, potential outcome measures, medications, and illustrative case reports to ensure the best possible outcomes for fetal and maternal patients. This text offers clear guidance on the common problems encountered in the day-to-day management of high-risk pregnancies. The seventh edition of Queenan\'s Management of High-Risk Pregnancy includes new and updated chapters with the most current evidence-based information and protocols available on topics such as infectious diseases in pregnancy, vaping, operative vaginal delivery, postpartum hemorrhage, pregnancies in women with disabilities, maternal anemia, malaria, and HIV infection. Queenan\'s Management of High-Risk Pregnancy: An Evidence-Based Approach, Seventh Edition, remains an indispensable reference and guide for obstetricians, gynecologists, OB/GYN trainees, midwives, and primary and general practitioners.
Cover Title Page Copyright Page Contents List of Contributors Foreword Preface Acknowledgments Part 1 Factors of High-Risk Pregnancy Chapter 1 Overview of High-Risk Pregnancy Chapter 2 Nutrition in Pregnancy Fetal growth Body mass index, weight gain, and adverse pregnancy outcomes Obesity Nutrition assessment and counseling Food security Energy intake during pregnancy Healthy dietary pattern in pregnancy Multivitamins Micronutrients in pregnancy Iron Folate/folic acid Calcium Vitamin D Iodine Vitamin toxicity Caffeine consumption in pregnancy Seafood consumption in pregnancy Multifetal pregnancy Nutrition during lactation Conclusion References Chapter 3 Alcohol and Substance Use Disorder Introduction Screening and testing for substance use disorder Alcohol Maternal effects Effects on the fetus Prenatal treatment Opioids Maternal effects Effects on the fetus Prenatal treatment Intrapartum and postpartum care Cannabis Stimulants Vaping (E-cigarettes) Benzodiazepines References Chapter 4 Environmental Agents and Reproductive Risk Background incidence of adverse outcome Biologic evidence of toxicity General principles Specific agents Lead Mercury Pesticides and herbicides Polychlorinated biphenyls Polybrominated diphenyl ethers Organic solvents Perfluorochemicals Video display terminals Bisphenol A Phthalates Air pollutants References Part 2 Genetics Chapter 5 Genetic Screening for Mendelian Disorders Family history Mendelian inheritance Carrier screening Carrier screening guidelines Hemoglobinopathies Cystic fibrosis Spinal muscular atrophy Fragile X syndrome Jewish genetic diseases Prenatal diagnosis Newborn screening References Chapter 6 Screening for Congenital Heart Disease Introduction Screening low-risk populations Benefits of cardiac screening High-risk populations for fetal echocardiography Normal fetal heart anatomy Technique Two-dimensional cross-sectional imaging Four-chamber view Ventricular outflow tracts Three-vessel and three-vessel trachea views Additional cardiac views Color Doppler imaging Expectations from cardiac screening Four-chamber view Addition of outflow tract views and three-vessel views Conclusion References Chapter 7 First- and Second-Trimester Screening for Fetal Aneuploidy and Neural Tube Defects First-trimester sonographic screening Combined first-trimester serum and sonographic screening First-trimester cystic hygroma Second-trimester sonographic screening Second-trimester serum screening Combined first- and second-trimester screening Screening in multiple gestations Screening for neural tube defects Cell-free fetal DNA (cffDNA) screening for fetal aneuploidy Scientific basis of cffDNA screening Limitations of cffDNA screening CffDNA screening performance Implementation of cffDNA testing in clinical practice References Part 3 Fetal Assessment Chapter 8 Sonographic Dating and Standard Fetal Biometry Pregnancy dating First trimester Second and third trimesters Estimation of fetal weight Macrosomia Fetal growth restriction Definition Symmetric versus asymmetric Timing of diagnosis Risk factors Outcome Management Fetal arterial Doppler Venous Doppler and fetal growth restriction Clinical application References Chapter 9 Antepartum Fetal Monitoring Nonstress test Biophysical profile Modified biophysical profile (NST/amniotic fluid volume) Doppler velocimetry References Chapter 10 Interpreting Intrapartum Fetal Heart Tracings Components of EFM documentation Baseline FHR Baseline FHR variability Accelerations Decelerations Uterine contractions Changes and trends in FHR over time Interpretation of EFM Category I Category III Category II Management of FHR abnormalities in labor Placement of internal monitors (intrauterine pressure catheter, fetal scalp electrode) Tachysystole with fetal heart rate changes Maternal hypotension Maternal repositioning Intravenous fluid bolus Maternal hyperoxygenation Amnioinfusion Fetal stimulation Future directions References Part 4 Maternal Disease Chapter 11 Sickle Cell Anemia Hemoglobin SCD Hemoglobin S/-thalassemia disease Management during pregnancy Acute pain Chronic pain Prophylactic red blood cell transfusions Other treatments Fetal assessment Labor and delivery Genetic evaluation CASE PRESENTATION References Chapter 12 Anemia Consequences Causes of anemia in pregnancy Diagnostic workup and treatment Macrocytic anemia Normocytic anemia Microcytic anemia Iron supplementation in pregnancy Treatment of iron deficiency anemia References Chapter 13 Thrombocytopenia Maternal thrombocytopenia Gestational thrombocytopenia Autoimmune thrombocytopenia HELLP Thrombotic thrombocytopenic purpura and atypical hemolytic uremic syndrome Other causes Fetal thrombocytopenia Autoimmune thrombocytopenia Alloimmune thrombocytopenia References Chapter 14 Inherited and Acquired Thrombophilias Overview of hemostasis changes during pregnancy Inherited thrombophilias Factor V Leiden Prothrombin gene mutation (G2021A) Protein C deficiency Protein S deficiency Antithrombin deficiency Acquired thrombophilia Antiphospholipid antibody syndrome Management considerations in patients with inherited or acquired thrombophilia Inherited thrombophilia Antiphospholipid antibody syndrome Summary References Chapter 15 Thromboembolic Disorders Physiology of hemostasis Platelet plug formation The coagulation cascade Endogenous anticoagulants Pathophysiology of and risk factors for thrombosis in pregnancy Diagnosis of venous thromboembolism Deep venous thrombosis Pulmonary embolus Conclusion References Chapter 16 Cardiac Disease in Pregnancy Risk assessment and risk-appropriate care Antenatal care and optimization First trimester Second trimester Third trimester Multidisciplinary delivery planning Mode of delivery Analgesia and anesthesia Monitoring and emergency preparedness Postpartum and interconception care Conclusion References Chapter 17 Renal Disease Physiological changes in renal function during pregnancy Anatomic changes in the urinary tract during pregnancy Renal disease in pregnancy Proteinuria Chronic kidney disease Mild renal insufficiency Moderate and severe renal insufficiency Hypertensive disorders with renal insufficiency Renal dialysis Renal transplantation Management of pregnancies complicated by renal disease Conclusion References Chapter 18 Pregnancy in Transplant Patients Prepregnancy assessment and counseling Antepartum care Review of common agents for maintenance immunosuppression Kidney transplant Other organ transplant patients Kidney-pancreas Liver Heart Lung Other transplant groups Uterus Intrapartum management Obstetric emergencies The baby References Chapter 19 Gestational Diabetes Mellitus Risk factors for gestational diabetes Therapeutic modalities in gestational diabetes Antenatal testing Delivery: when and how to deliver Postpartum considerations References Chapter 20 Diabetes Mellitus Initial evaluation Regulating maternal glycemia Management during pregnancy Management of insulin during labor References Chapter 21 Thyroid Disorders Diagnosis Additional studies Hypothyroidism Implications for pregnancy Treatment Hyperthyroidism Implications for pregnancy Management Thyroid storm management [3,4,10] References Chapter 22 Asthma Definition of asthma Effect of pregnancy on the course of asthma Clinical observations Mechanisms Effect of asthma on pregnancy Clinical observations Mechanisms Diagnosis of asthma during pregnancy Management Assessment and monitoring Control of factors contributing to severity Patient education Pharmacologic therapy Chronic asthma Acute asthma Management during labor and delivery Conclusion References Chapter 23 Epilepsy Contraception Fertility Preconception counseling Folic acid Seizures during pregnancy ASM risks: Structural and neurodevelopmental teratogenicity Management during pregnancy Prenatal screening ASM levels Peripartum care Labor and delivery Maternal outcomes Postpartum care ASM management and seizure risk Breastfeeding Postpartum depression Summary References Chapter 24 Chronic Hypertension Definition Diagnosis Preconceptional counseling Morbidity and mortality Diagnosis and evaluation in pregnancy Treatment during pregnancy Antepartum fetal assessment Delivery Postpartum care References Chapter 25 Systemic Lupus Erythematosus Epidemiology Etiology Pathogenesis Differential diagnosis Morbidity General morbidity and mortality Effects of pregnancy on systemic lupus erythematosus Effects of systemic lupus erythematosus on pregnancy Management during pregnancy Antiphospholipid antibodies References Chapter 26 Perinatal Infections Parvovirus B19 Clinical manifestations Diagnosis Management of parvovirus B19 in pregnancy Rubella Clinical manifestations Diagnosis Management and prevention Syphilis Clinical manifestations Diagnosis Treatment Toxoplasmosis Clinical manifestations Diagnosis Management and prevention Herpes simplex infection Clinical manifestations Diagnosis Management and prevention Cytomegalovirus Clinical manifestations Diagnosis Management and prevention Varicella zoster virus Clinical manifestations Diagnosis Management and prevention Group B Streptococcus Clinical manifestations Diagnosis Management and prevention References Chapter 27 Malaria Clinical features Diagnosis Treatment Complications Prevention References Chapter 28 Hepatitis in Pregnancy Hepatitis A Hepatitis E Hepatitis B Interaction of HBV with physiology of the pregnant immune system Maternal screening Prevention of HBV infection Treatment of mothers with HBV Elective cesarean section vs. vaginal delivery Breastfeeding Hepatitis D Hepatitis C Epidemiology Screening Diagnostic algorithm Additional monitoring and management considerations during pregnancy Treatment Breastfeeding Hepatitis G References Chapter 29 HIV Infection Identifying infected patients Posttest counseling of pregnant patients with HIV Laboratory assessment of the pregnant patient with HIV Recommended immunizations for pregnant patients with HIV Antiretroviral treatment in pregnancy Labor and delivery care for pregnant patients living with HIV Postpartum care for pregnant patients living with HIV Ethical and legal considerations Conclusion References Chapter 30 Pregnancy in Women with Disabilities General considerations Demographic disadvantages Prepregnancy health and wellness Medication use Psychosocial risk factors Abuse Mental health Tobacco, alcohol, and substance use and misuse Weight gain, mobility, and skin integrity Urinary tract function and infections Respiratory complications Venous thromboembolic disease Antepartum consultation Barriers to care Pregnancy outcomes Across disability types Cesarean delivery Considerations for specific disability types and associated conditions Intellectual and developmental disabilities Sensory disabilities Breastfeeding Conclusion References Chapter 31 COVID-19 in Pregnancy Pathophysiology of COVID in pregnancy Epidemiology Screening and Prevention Vaccination Clinical course Vertical transmission Clinical management Treatment Postpartum care and newborns References Part 5 Obstetric Complications Chapter 32 Recurrent Pregnancy Loss Factors contributing to recurrent pregnancy loss Genetic abnormalities Uterine abnormalities Immunologic factors Hematologic factors Antiphospholipid antibody syndrome Inherited thrombophilias Endocrinopathies Vitamin D deficiency Polycystic ovary syndrome Obesity and other social factors Male factor Infections Evidence-based evaluation of couples experiencing recurrent pregnancy loss Chapter 33 Cervical Insufficiency Syndrome of spontaneous preterm birth How can we make the clinical diagnosis of cervical insufficiency, and how effective is cerclage for a history indication? Should insufficiency be a sonographic diagnosis? Can ultrasound replace the history indication? What is acute cervical insufficiency and how effective is a physical exam-indicated cerclage? Can acute cervical insufficiency be predicted and managed? When should cerclage be placed in a twin gestation? How should women with a prior failed vaginal cerclage be managed? Do cervical procedures cause insufficiency? What surgical techniques are used for history or ultrasound-indicated vaginal cerclage? Should postcerclage activity restrictions be recommended? When should a cerclage be removed? Cerclage complications Adjunctive management strategies for cervical insufficiency Conclusion References Chapter 34 Gestational Hypertension, Preeclampsia, and Eclampsia Pathophysiology Diagnosis Gestational hypertension Severe gestational hypertension Proteinuria Edema Preeclampsia Preeclampsia with severe features Eclampsia HELLP Management Initial evaluation Gestational hypertension and preeclampsia without severe features 37 weeks or more Less than 37 weeks Preeclampsia with severe features or severe gestational hypertension Management of preeclampsia with severe features or severe gestational hypertension HELLP Eclampsia Complications of preeclampsia and HELLP Intrapartum management of preeclampsia with severe features Postpartum management Follow up and maternal counseling References Chapter 35 Postpartum Hemorrhage Hematologic parameters Defining excessive blood loss Prevention Risk factors and etiologies Uterine atony Methylergonovine/ergometrine Prostaglandins Misoprostol Mechanical and surgical control of bleeding Uterine tamponade Uterine compression sutures Uterine devascularization Arterial embolization Hysterectomy Pelvic packing Uterine inversion Management Genital tract lacerations Uterine rupture Retained placenta Placenta accreta spectrum disorder Treatment Complications Conclusion References Chapter 36 Emergency Care Timely and dynamic assessment of trauma Primary survey Secondary survey Diagnostic studies Cardiac arrest in pregnancy Circulation Airway and breathing Postarrest care Stabilization and resuscitation Principles of resuscitation in hemorrhagic shock Principles of resuscitation in septic shock Optimizing resource use in emergency care Suggested readings Chapter 37 Rh and Other Blood Group Alloimmunizations Prophylaxis Methods of surveillance Antibody titer Ultrasound Fetal blood typing through DNA analysis Overall clinical management First sensitized pregnancy Previous severely affected fetus or infant (previous child requiring intrauterine or neonatal transfusion) Intrauterine transfusion Outcome Immunomodulation Hemolytic disease of the fetus and newborn caused by non-RhD antibodies References Chapter 38 Multiple Gestations Impact on perinatal outcomes Zygosity and chorionicity Embryology Ultrasound diagnosis of chorionicity Fetal complications and multiple gestations Intrauterine growth restriction and growth discordance Fetal loss Discordant congenital anomalies Complications unique to monochorionicity Monoamnionicity Twin–twin transfusion syndrome Maternal obstetric complications Antepartum management of multiple gestations Multifetal pregnancy reduction Prenatal diagnosis Screening for fetal aneuploidy Diagnostic testing for fetal aneuploidy Screening for neural tube defects in multiples Screening for anatomic abnormalities Prevention of preterm delivery Antenatal surveillance Intrapartum period Conclusion References Chapter 39 Polyhydramnios and Oligohydramnios Normal amniotic fluid composition and volume Dynamics of amniotic fluid turnover Fetal urine Fetal lung fluid Fetal swallowing Intramembranous flow Amniotic fluid turnover Clinical measurement of amniotic fluid Polyhydramnios Definition Diagnosis Associations Evaluation Management Future therapies Oligohydramnios Definition Diagnosis Clinical significance Premature rupture of membranes Congenital malformation Intrauterine growth restriction Postdate pregnancy Twin pregnancy Management Conclusion References Chapter 40 Pathogenesis and Prediction of Preterm Delivery Etiology and pathogenesis of spontaneous preterm delivery Idiopathic and stress-associated premature activation of the maternal-placental–fetal hypothalamic–pituitary–adrenal axis Placental corticotropin-releasing hormone (CRH) and accelerated HPA activation FK506-binding protein 51 and intracellular functional progesterone (P4) withdrawal Decidual-amnion-chorion inflammation The vaginal microbiome and preterm delivery Maternal genital tract inflammation and preterm delivery Abruption-associated preterm delivery Mechanical stretching of the uterus Final common pathway of preterm delivery Prediction of preterm delivery: interpretation of test results Pathway-specific markers Inflammatory biomarkers Biomarkers of decidual hemorrhage and dysregulation in coagulation pathways Markers of the final preterm delivery common pathway References Chapter 41 Preterm (Prelabor) Premature Rupture of Membranes Mechanisms Prediction and prevention Diagnosis Clinical course Evaluation Management Preterm premature rupture of membranes at 32 to 36 weeks of gestation Premature rupture of membranes before 32 weeks of gestation Previable premature rupture of membranes before the limit of viability Special circumstances Cerclage Herpes simplex virus Human immunodeficiency virus (HIV) Resealing of the membranes References Chapter 42 Management of Preterm Labor Evaluation: history, physical exam, and screening tests Initial assessment Diagnosis of preterm labor Fetal fibronectin and cervical length Management Prophylaxis to prevent neonatal morbidity/mortality from preterm birth (fetal maturation) Neuroprotection Nontocolytic interventions Bed rest Hydration Prophylactic antibiotics Group B streptococcus prophylaxis Progesterone Tocolysis Primary tocolysis – single agent Additional tocolysis and antibiotics used simultaneously Refractory tocolysis – primary agent is failing Maintenance tocolysis – after successful primary tocolysis Mode of delivery References Chapter 43 Placenta Previa and Related Disorders Placenta previa Definitions Clinical significance Incidence, pathophysiology, and risk factors Clinical presentation Diagnosis Management Timing and mode of delivery Vasa previa Pathophysiology Incidence and risk factors Diagnosis Management Mode and timing of delivery Placenta accreta spectrum Clinical significance Pathophysiology Incidence and risk factors Diagnosis Management Timing and mode of delivery Conclusion References Chapter 44 Fetal Growth Restriction Definition of fetal growth restriction Epidemiology Perinatal morbidity and mortality Etiologies Diagnosis Management of FGR Antenatal surveillance Timing of delivery in FGR References Part 6 Complications of Labor and Delivery Chapter 45 Induction of Labor Indications and contraindications to labor induction Medically indicated delivery timing Elective induction of labor Predicting a successful induction Defining failed induction Preinduction considerations Cervical ripening Risks associated with labor induction Uterine tachysystole Hyponatremia Hypotension Additional considerations Immediate vs. delayed pushing Induction of labor in women with prior cesarean delivery Conclusion References Chapter 46 Cesarean Delivery Maternal and perinatal morbidity and mortality Evidence-based operative considerations Preoperative considerations Intraoperative considerations Antibiotic prophylaxis Vaginal antiseptic prophylaxis Abdominal surgical incision Manual removal of the placenta Extraabdominal vs. intraabdominal repair of the uterine incision Single-layer vs. two-layer hysterotomy closure Peritoneal closure Abdominal wall closure techniques Postoperative considerations Pain regimens Thromboprophylaxis Potential risks of repeat cesarean delivery Current indications for cesarean delivery Failure to progress in labor Fetal distress Malpresentation Repeat cesarean References Chapter 47 Vaginal Birth after Cesarean Delivery Trends in vaginal birth after cesarean-trial of labor Candidates for trial of labor Factors affecting the success rates for trial of labor Maternal demographics Prior indication for cesarean delivery Prior vaginal delivery Birthweight Labor status and cervical examination Previous incision type Multiple prior cesarean deliveries Risks of vaginal birth after cesarean-trial of labor Uterine rupture Number of prior cesarean deliveries Prior vaginal delivery Uterine closure technique Interpregnancy interval Labor induction Labor augmentation Sonographic evaluation of the uterine scar Management of vaginal birth after cesarean-trial of labor Counseling for vaginal birth after cesarean-trial of labor References Chapter 48 Breech Delivery Types of breech Diagnosis Prevention Complications of vaginal breech delivery Approach to management External cephalic version at or near term Planned mode of delivery Delivery planning Vaginal breech delivery Criteria for vaginal beech delivery Induction and augmentation of labor Care during labor Conduct of vaginal breech delivery Cesarean breech delivery Complications to anticipate Twin pregnancy with leading breech presentation Noncephalic second twin Internal podalic version and total breech extraction for cephalic second twins Preterm breech birth Training Conclusion Acknowledgments References Chapter 49 Operative Vaginal Delivery Prerequisites and indications Classification Instrument selection Site of delivery Technique Forceps Vacuum extraction Outcomes Maternal Neonatal Training Conclusion References Chapter 50 Obstetric Analgesia and Anesthesia Labor and vaginal delivery Consequences of unrelieved pain Multimodal regional analgesia Epidural, spinal, and combined spinal–epidural analgesia Patient-controlled epidural analgesia Timing of regional pain relief Cesarean delivery Postoperative analgesia Opioid crisis Compromised coagulation and neuraxial regional analgesia and anesthesia References Chapter 51 Quality and Patient Safety Patient safety in obstetrics How to measure safety Outcome measures Process measures Structure and culture measures Tools to improve patient safety Evidence to support improvement tools Beyond safety and quality References Part 7 Procedures Chapter 52 Genetic Amniocentesis, Chorionic Villus Sampling, Intrauterine Transfusion, and Shunts Prenatal diagnosis Chorionic villus sampling Transcervical chorionic villus sampling Transabdominal chorionic villus sampling Complications of chorionic villus sampling Amniocentesis Traditional amniocentesis (15 weeks gestation) Early amniocentesis (<14 weeks gestation) Multiple gestations Complications of amniocentesis Diagnostic studies Fluorescence in Situ Hybridization Karyotype Chromosomal microarray Next generation sequencing Intrauterine Transfusion Intraperitoneal approach to IUT Intravascular access for fetal transfusion Technique for IUT Complications Fetal shunts Vesicoamniotic shunt Thoracoamniotic shunts Technique for shunt placement Complications of shunts References Chapter 53 Fetal Surgery Different fetal techniques Open fetal surgery (hysterotomy) Fetoscopic surgery Ultrasound-guided percutaneous fetal therapy Specific diseases Myelomeningocele Congenital lung lesions Sacrococcygeal teratoma Congenital diaphragmatic hernia Twin–twin transfusion syndrome, twin anemia-polycythemia sequence Fetal obstructive uropathies and renal diseases Fetal molecular therapies Conclusion References Index Supplemental Images EULA